These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 1093389)
1. Immunization of children with attenuated measles-rubella bivalent vaccine. Ramos-Alvarez M; Miller BH; Jackson JE; Schwarz AJ; Bessudo L Am J Dis Child; 1975 Apr; 129(4):474-7. PubMed ID: 1093389 [TBL] [Abstract][Full Text] [Related]
2. A field with a liver measles-mumps-rubella vaccine. Walters VW; Miller SA; Jackson JE; Kenny MT Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294 [TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of a new measles-mumps-rubella trivalent vaccine. Schwarz AJ; Jackson JE; Ehrenkranz NJ; Ventura A; Schiff GM; Walters VW Am J Dis Child; 1975 Dec; 129(12):1408-12. PubMed ID: 128287 [TBL] [Abstract][Full Text] [Related]
4. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial. Swartz TA; Klingberg W; Klingberg MA Infection; 1974; 2(3):115-7. PubMed ID: 4606362 [No Abstract] [Full Text] [Related]
5. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic. Ehrenkranz NJ; Ventura AK; Medler EM; Jackson JE; Kenny MT Bull World Health Organ; 1975; 52(1):81-5. PubMed ID: 764997 [TBL] [Abstract][Full Text] [Related]
6. [Immunization of healthy children with mumps-rubella bivalent live vaccine and simultaneous vaccination with mumps-rubella and varicella vaccines]. Takayama N; Kidokoro M; Suzuki K; Morita M Kansenshogaku Zasshi; 1991 Oct; 65(10):1271-5. PubMed ID: 1791323 [TBL] [Abstract][Full Text] [Related]
7. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella]. Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G Minerva Pediatr; 1990 Dec; 42(12):531-6. PubMed ID: 2087226 [TBL] [Abstract][Full Text] [Related]
9. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
10. Control of measles and rubella through use of attenuated vaccines. Meyer HM; Hopps HE; Parkman PD; Ennis FA Am J Clin Pathol; 1978 Jul; 70(1 Suppl):128-35. PubMed ID: 685885 [TBL] [Abstract][Full Text] [Related]
11. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines. Weibel RE; Buynak EB; McLean AA; Hilleman MR Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873 [TBL] [Abstract][Full Text] [Related]
12. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. Vesikari T; Ala-Laurila EL; Heikkinen A; Terho A; D'Hondt E; André FE Am J Dis Child; 1984 Sep; 138(9):843-7. PubMed ID: 6383020 [TBL] [Abstract][Full Text] [Related]
13. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278 [TBL] [Abstract][Full Text] [Related]
14. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children. Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106 [TBL] [Abstract][Full Text] [Related]
15. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps. Smorodintsev AA; Nasibov MN; Jakovleva NV Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140 [TBL] [Abstract][Full Text] [Related]